(Q63727492)
Statements
Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden (English)
Kathrine Lederballe Grøn
Bente Glintborg
Frank Mehnert
Mikkel Østergaard
Lene Dreyer
Niels Steen Krogh
Johan Askling
Merete Lund Hetland
ARTIS Study Group